EVOTEC
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.
EVOTEC
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
1993-01-01
Address:
Hamburg, Hamburg, Germany
Country:
Germany
Website Url:
http://www.evotec.com
Total Employee:
1001+
Status:
Active
Contact:
+49 0 40 560 81 -0
Total Funding:
482.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Enterin
Philadelphia-based biotechnology company .
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Board_member
Advisor
Current Employees Featured
Manfred Eigen Co-Founder @ Evotec
Co-Founder
Heinrich M. Schulte Co-Founder @ Evotec
Co-Founder
Werner Lanthaler CEO @ Evotec
CEO
2009-02-01
Enno Spillner Chief Financial Officer @ Evotec
Chief Financial Officer
2016-07-01
Craig Johnstone Chief Operating Officer @ Evotec
Chief Operating Officer
2019-01-01
Cord Dohrmann CSO & Managment board member @ Evotec
CSO & Managment board member
2010-01-01
Dimitar Hristozov Group Leader & Research Informatics @ Evotec
Group Leader & Research Informatics
2019-04-01
Freimut Leidenberger Co-Founder @ Evotec
Co-Founder
Rudolf Rigler Co-Founder @ Evotec
Co-Founder
Cony D'Cruz Senior Vice President, Business Development @ Evotec
Senior Vice President, Business Development
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-22 | Central Glass Germany | Central Glass Germany acquired by Evotec | N/A |
| 2022-05-30 | Rigenerand Srl | Rigenerand Srl acquired by Evotec | 23 M EUR |
| 2019-05-20 | Just - Evotec Biologics | Just - Evotec Biologics acquired by Evotec | 90 M USD |
| 2017-07-30 | Aptuit LLC | Aptuit LLC acquired by Evotec | 300 M USD |
| 2016-10-26 | Cyprotex | Cyprotex acquired by Evotec | 55.7 M GBP |
| 2014-05-28 | Euprotec | Euprotec acquired by Evotec | 3.15 M USD |
| 2014-03-24 | Bionamics GmbH | Bionamics GmbH acquired by Evotec | N/A |
| 2013-01-03 | Cell Culture Service GmbH | Cell Culture Service GmbH acquired by Evotec | 1.2 M EUR |
| 2011-06-01 | Compound Focus | Compound Focus acquired by Evotec | N/A |
| 2011-04-19 | KINAXO Biotechnologies | KINAXO Biotechnologies acquired by Evotec | N/A |
Investors List
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - Evotec
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Evotec
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Evotec
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Evotec
Mubadala
Mubadala investment in Post-IPO Equity - Evotec
CARB-X
CARB-X investment in Grant - Evotec
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Evotec
Biotechnology Value Fund
Biotechnology Value Fund investment in Venture Round - Evotec
3i Group
3i Group investment in Venture Round - Evotec
Gilde Healthcare
Gilde Healthcare investment in Venture Round - Evotec
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-03 | Tubulis | Evotec investment in Series B - Tubulis | 60 M EUR |
| 2022-02-16 | Centauri Therapeutics | Evotec investment in Series A - Centauri Therapeutics | 24 M GBP |
| 2022-02-15 | IMIDomics | Evotec investment in Corporate Round - IMIDomics | N/A |
| 2021-08-18 | Immunitas Therapeutics | Evotec investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-07-29 | Topas Therapeutics | Evotec investment in Series B - Topas Therapeutics | 18 M EUR |
| 2021-04-21 | OxVax | Evotec investment in Seed Round - OxVax | N/A |
| 2021-03-04 | Exscientia | Evotec investment in Series C - Exscientia | 40 M USD |
| 2021-03-02 | ARGOBIO | Evotec investment in Funding Round - ARGOBIO | 50 M EUR |
| 2021-01-08 | Blacksmith Medicines | Evotec investment in Seed Round - Blacksmith Medicines | N/A |
| 2020-06-24 | Autobahn Labs | Evotec investment in Seed Round - Autobahn Labs | N/A |
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as exhibitor
Official Site Inspections
http://www.evotec.com Semrush global rank: 818.04 K Semrush visits lastest month: 47.29 K
- Host name: web01.evotec.com
- IP address: 37.208.107.46
- Location: Offenbach Germany
- Latitude: 50.123
- Longitude: 8.7921
- Timezone: Europe/Berlin
- Postal: 63075
More informations about "Evotec"
About Us | Evotec - Evotec
Discovery who is Evotec and what Evotec does as we work independently, together and for our partners for medicines that matter.See details»
About Us - Evotec
At Evotec, our mission is clear, we're dedicated to discovering, developing and manufacturing medicines that matter for patients worldwide. In highly efficient collaborations together with our partners, we focus on data-driven precision …See details»
Evotec - Wikipedia
In 2008, Evotec acquired US-based Renovis in a $152 million stock deal, allowing it to list on the Nasdaq stock exchange. One year later, the company announced it was voluntarily de-listing its American Depositary Receipt to cut costs and concentrate its share trading on the German TecDAX platform. In 2010, the company acquired DeveloGen AG, a spin-out from the Max Planck Institute for Biophysical ChemistrySee details»
Evotec - Crunchbase Company Profile & Funding
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and …See details»
Evotec SE Profile | The Scientist
Mar 6, 2025 Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the …See details»
Evotec - LinkedIn
Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs ...See details»
Evotec - The Org
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical …See details»
Evotec - Leadership Team | The Org
About The Leadership Team at Evotec plays a crucial role in guiding the company's strategic direction and ensuring operational excellence across its drug discovery and development …See details»
Evotec AG - Org Chart, Teams, Culture & Jobs | The Org
View Evotec AG's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Our Company | Evotec
Welcome to Evotec, where we are driven by a singular purpose: to be at the forefront of advancing medicine that truly matters. As a leading drug discovery and development company, we …See details»
Life at Evotec
At Evotec, collaboration, team spirit and regular interactions are fundamental aspects of our work culture, complemented by access to state-of-the-art labs and workspaces. By leveraging …See details»
Org Chart Evotec - The Official Board
The org chart of Evotec contains its 37 main executives including Christian Wojczewski, Paul Hitchin and Ryan Brady.See details»
Evotec Receives $ 2.5 m Grant to Generate Next Generation
2 days ago Gates Foundation supports Evotec with a$ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.. HAMBURG, DE/ …See details»
Evotec Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Evotec has 5 employees across 16 locations and €781.43 m in annual revenue in FY 2023. See insights on Evotec including office locations, competitors, revenue, financials, …See details»
Evotec, target of acquisition: At what cost for biotech?
Nov 25, 2024 As a contract research organization (CRO), it collaborates with some of the world’s largest pharmaceutical companies to accelerate drug discovery, but what sets Evotec …See details»
Joining Evotec
Join the Evotec community, where you become an integral part of our global team of over 5000 professionals spread across 17 locations in 6 countries.See details»
Evotec Receives $ 2.5 m Grant to Generate Next Generation …
2 days ago Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations. The collaboration …See details»
Our People - Evotec
Learn more about Evotec's greatest asset, our people. Gain insights into the individuals behind Evotec's groundbreaking work, their expertise, and accomplishments that collectively …See details»
Evotec SE unveils new strategy and provides 2025 g…
Apr 17, 2025 EQS-News: Evotec SE / Key word (s): Annual Report Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results 17.04.2025 / 07:00 …See details»
Evotec - Overview, News & Similar companies | ZoomInfo.com
Just Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, …See details»